Physician Adherence to ACR Gout Treatment Guidelines: Perception Versus Practice

被引:29
作者
Oderda, Gary. M. [1 ]
Shiozawa, Aki [2 ]
Walsh, Michael [3 ]
Hess, Kyle [3 ]
Brixner, Diana I. [4 ,5 ]
Feehan, Michael [3 ,6 ]
Akhras, Kasem [7 ]
机构
[1] Univ Utah, Coll Pharm, Pharmacotherapy Outcomes Res Ctr, Salt Lake City, UT 84112 USA
[2] Takeda Pharmaceut Int Inc, Global Outcome Res, Deerfield, IL USA
[3] The Modellers, Salt Lake City, UT USA
[4] Univ Utah, Dept Pharmacotherapy, Salt Lake City, UT USA
[5] Pharmacotherapy Outcomes Res Ctr, Salt Lake City, UT USA
[6] Univ Utah, Coll Pharm, Salt Lake City, UT 84112 USA
[7] Takeda Pharmaceut Int Inc, Deerfield, IL USA
关键词
gout; ACR gout guidelines; serum uric acid (sUA); urate lowering therapy (ULT); prophylactic treatment; physician adherence; OF-RHEUMATOLOGY GUIDELINES; HYPERURICEMIA; MANAGEMENT; THERAPY; POPULATION; PREVALENCE;
D O I
10.3810/pgm.2014.05.2774
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: In October 2012, the American College of Rheumatology (ACR) published recommendations for chronic gout treatment goals and pharmacotherapy. Objectives: Identify potential gaps between real-world chronic gout treatment, ACR guideline recommendations, and physicians' perceived guideline adherence by evaluating records of patients classified as having "higher" and "lower" guideline adherence as defined by the investigators. Methods: A comprehensive quantitative survey was administered between February 11 and February 22, 2013, to physicians treating patients with gout; the survey included a patient record chart review informed by prior qualitative interviews. Eight criteria from the ACR gout management guidelines were used to compose the survey. To assess ACR guideline adherence, information from records of patients with chronic gout treated by primary care physicians (PCPs) and rheumatologists was scored from 0 (no adherence) to 8 (total adherence), in accordance with ACR guideline recommendations. Physicians also indicated how closely they believed patient treatment followed current guidelines on a 10-point scale. Results: Of the 350 records of patients with chronic gout, all but 3 PCP patients were adherent on >= 1 guideline recommendation, but nearly all patients could be considered nonadherent, considering all potential recommendations. Patients with chronic gout treated by rheumatologists tended to be managed more closely to ACR guidelines than patients treated by PCPs (mean scores: rheumatologists 5.8/8 +/- 1.7 vs 4.3/8 +/- 1.7 for PCPs). Among patients classified as having "higher adherence" based on adherence scores, there was low adherence on first-line urate lowering therapy dose, acute prophylaxis dosing, and length of prophylaxis treatment. Among PCPs and rheumatologists, there was a disparity between how closely physicians believed patient treatment followed guidelines and actual adherence with ACR guidelines based on adherence scores. For 16.4% of patients treated by PCPs and 18.4% of patients seen by rheumatologists, physicians believed they closely followed ACR guidelines (score of 8-10/10) for each patient; but in actuality, adherence was lower. Conclusion: Although adherence with ACR guidelines is higher among rheumatologists than PCPs in treating patients with gout, overall adherence could be improved by both specialties.
引用
收藏
页码:257 / 267
页数:11
相关论文
共 19 条
[1]  
Agudelo CA, 1998, CLIN GERIATR MED, V14, P495
[2]  
[Anonymous], 2016, GOUT
[3]   The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial [J].
Becker, Michael A. ;
Schumacher, H. Ralph ;
Espinoza, Luis R. ;
Wells, Alvin F. ;
MacDonald, Patricia ;
Lloyd, Eric ;
Lademacher, Christopher .
ARTHRITIS RESEARCH & THERAPY, 2010, 12 (02)
[4]   On the brink of novel therapeutic options for an ancient disease [J].
Bieber, JD ;
Terkeltaub, RA .
ARTHRITIS AND RHEUMATISM, 2004, 50 (08) :2400-2414
[5]  
Brixner DI, 2005, AM J MANAG CARE, V11, pS459
[6]   Latest evidence on gout management: what the clinician needs to know [J].
Burns, Christopher M. ;
Wortmann, Robert L. .
THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2012, 3 (06) :271-286
[7]  
Cabana M, 1998, AM J MANAG CARE, V4, pS741
[8]   Patients' knowledge and beliefs concerning gout and its treatment: a population based study [J].
Harrold, Leslie R. ;
Mazor, Kathleen M. ;
Peterson, Daniel ;
Naz, Nausheen ;
Firneno, Cassandra ;
Yood, Robert A. .
BMC MUSCULOSKELETAL DISORDERS, 2012, 13
[9]   2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia [J].
Khanna, Dinesh ;
Fitzgerald, John D. ;
Khanna, Puja P. ;
Bae, Sangmee ;
Singh, Manjit K. ;
Neogi, Tuhina ;
Pillinger, Michael H. ;
Merill, Joan ;
Lee, Susan ;
Prakash, Shraddha ;
Kaldas, Marian ;
Gogia, Maneesh ;
Perez-Ruiz, Fernando ;
Taylor, Will ;
Liote, Frederic ;
Choi, Hyon ;
Singh, Jasvinder A. ;
Dalbeth, Nicola ;
Kaplan, Sanford ;
Niyyar, Vandana ;
Jones, Danielle ;
Yarows, Steven A. ;
Roessler, Blake ;
Kerr, Gail ;
King, Charles ;
Levy, Gerald ;
Furst, Daniel E. ;
Edwards, N. Lawrence ;
Mandell, Brian ;
Schumacher, H. Ralph ;
Robbins, Mark ;
Wenger, Neil ;
Terkeltaub, Robert .
ARTHRITIS CARE & RESEARCH, 2012, 64 (10) :1431-1446
[10]   2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis [J].
Khanna, Dinesh ;
Khanna, Puja P. ;
Fitzgerald, John D. ;
Singh, Manjit K. ;
Bae, Sangmee ;
Neogi, Tuhina ;
Pillinger, Michael H. ;
Merill, Joan ;
Lee, Susan ;
Prakash, Shraddha ;
Kaldas, Marian ;
Gogia, Maneesh ;
Perez-Ruiz, Fernando ;
Taylor, Will ;
Liote, Frederic ;
Choi, Hyon ;
Singh, Jasvinder A. ;
Dalbeth, Nicola ;
Kaplan, Sanford ;
Niyyar, Vandana ;
Jones, Danielle ;
Yarows, Steven A. ;
Roessler, Blake ;
Kerr, Gail ;
King, Charles ;
Levy, Gerald ;
Furst, Daniel E. ;
Edwards, N. Lawrence ;
Mandell, Brian ;
Schumacher, H. Ralph ;
Robbins, Mark ;
Wenger, Neil ;
Terkeltaub, Robert .
ARTHRITIS CARE & RESEARCH, 2012, 64 (10) :1447-1461